These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 17696578)

  • 1. Safety profile of meropenem: an updated review of over 6,000 patients treated with meropenem.
    Linden P
    Drug Saf; 2007; 30(8):657-68. PubMed ID: 17696578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety profile of meropenem: a review of nearly 5,000 patients treated with meropenem.
    Norrby SR; Gildon KM
    Scand J Infect Dis; 1999; 31(1):3-10. PubMed ID: 10381210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety profile of meropenem: international clinical experience based on the first 3125 patients treated with meropenem.
    Norrby SR; Newell PA; Faulkner KL; Lesky W
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():207-23. PubMed ID: 8543496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meropenem: a review of its use in the treatment of serious bacterial infections.
    Baldwin CM; Lyseng-Williamson KA; Keam SJ
    Drugs; 2008; 68(6):803-38. PubMed ID: 18416587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meropenem: an updated review of its use in the management of intra-abdominal infections.
    Lowe MN; Lamb HM
    Drugs; 2000 Sep; 60(3):619-46. PubMed ID: 11030471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.
    Wiseman LR; Wagstaff AJ; Brogden RN; Bryson HM
    Drugs; 1995 Jul; 50(1):73-101. PubMed ID: 7588092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meropenem: a review of its use in patients in intensive care.
    Hurst M; Lamb HM
    Drugs; 2000 Mar; 59(3):653-80. PubMed ID: 10776838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the efficacy and tolerability of meropenem in the treatment of serious bacterial infections.
    Mohr JF
    Clin Infect Dis; 2008 Sep; 47 Suppl 1():S41-51. PubMed ID: 18713049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meropenem versus imipenem-cilastatin for the treatment of hospitalized patients with complicated skin and skin structure infections: results of a multicenter, randomized, double-blind comparative study.
    Fabian TC; File TM; Embil JM; Krige JE; Klein S; Rose A; Melnick D; Soto NE
    Surg Infect (Larchmt); 2005; 6(3):269-82. PubMed ID: 16201937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biapenem.
    Perry CM; Ibbotson T
    Drugs; 2002; 62(15):2221-34; discussion 2235. PubMed ID: 12381221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meropenem, a new carbapenem antibiotic.
    Fish DN; Singletary TJ
    Pharmacotherapy; 1997; 17(4):644-69. PubMed ID: 9250544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A post hoc subgroup analysis of meropenem versus imipenem/cilastatin in a multicenter, double-blind, randomized study of complicated skin and skin-structure infections in patients with diabetes mellitus.
    Embil JM; Soto NE; Melnick DA
    Clin Ther; 2006 Aug; 28(8):1164-1174. PubMed ID: 16982293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of a randomized, multicenter trial of meropenem versus clindamycin/tobramycin for the treatment of intra-abdominal infections.
    Wilson SE
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S197-206. PubMed ID: 9126694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.
    Matthews SJ; Lancaster JW
    Clin Ther; 2009 Jan; 31(1):42-63. PubMed ID: 19243706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of meropenem in the treatment of serious infections in children: review of the current literature.
    Arrieta A
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S207-12. PubMed ID: 9126695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical pharmacology and indications of meropenem in severe pediatric infection].
    Honorato J; Sádaba B; Díaz M
    Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():38-44. PubMed ID: 9410068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imipenem/cilastatin: the first carbapenem antibiotic.
    Lyon JA
    Drug Intell Clin Pharm; 1985 Dec; 19(12):895-9. PubMed ID: 3910385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open-label study to evaluate the pharmacodynamics, clinical efficacy, and safety of meropenem for adult bacterial meningitis in Japan.
    Morita A; Kamei S; Minami M; Yoshida K; Kawabata S; Kuroda H; Suzuki Y; Araki N; Iwasaki Y; Kobayashi R; Hayashi N; Hirayama T; Ochiai J; Ueda M; Yamagishi Y; Niwa J; Shindo K; Fukushima Y; Takita T; Sato T; Sato S; Mikamo H; Iwata S
    J Infect Chemother; 2014 Sep; 20(9):535-40. PubMed ID: 24882451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbapenems in serious infections: a risk-benefit assessment.
    Norrby SR
    Drug Saf; 2000 Mar; 22(3):191-4. PubMed ID: 10738843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.